Company Analysis

Agios Pharmaceuticals, Inc. (AGIO)

Nasdaq: AGIO · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 2008
Grade5.6
◀ Past 5.8● Present 5.9▶ Future 5.0
1 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 12, 2026Feb 13, 2025Feb 15, 2024Feb 23, 2023Feb 24, 2022Feb 25, 2021Feb 19, 2020Feb 14, 2019Feb 14, 2018Feb 16, 2017
Revenue54,02836,49826,82314,24000r117,91294,38743,01169,892
Cost of revenue6,3454,1652,8811,70400r1,3171,39700
Research and development339,535301,286295,526279,910256,973220,811r214,262r341,324292,681220,163
Selling, general and administrative180,280156,784119,903121,673121,445115,105r102,007r114,14571,12450,714
General and administrative········71,12450,714
Total operating expenses·······456,866363,805270,877
Total costs and expenses526,160462,235418,310403,287378,418335,916r316,269r456,866363,805·
Operating income-472,132-425,737-391,487-389,047-378,418-335,916r-316,269r-362,479-320,794-200,985
Interest and investment income···12,7938366,61114,86116,4516,1242,514
Interest income (expense), net56,37948,08333,34412,793836·····
Other income (expense), net1,9566,4876,0556,74914,43300···
Income before income taxes-413,797717,969-352,088-231,801-356,510-329,305-301,408-346,028-314,670-198,471
Income tax expense-1,01644,24400··0000
Income from continuing operations··-352,088-231,801-356,510-329,305-301,408···
Income from discontinued operations··001,961,2251,935-110,064···
Net income-412,781673,725-352,088-231,8011,604,715-327,370-411,472-346,028-314,670-198,471
Earnings per share, basic-7.1211.86-6.33-4.2326.55-4.74-6.86···
Earnings per share, diluted-7.1211.64-6.33-4.2326.55-4.74-6.86···
Earnings per share, basic and diluted·····-4.74-6.86-6.03-6.75-5.07
Weighted average shares, basic57,972,00456,807,41555,651,48754,789,43560,447,34668,997,87959,994,539···
Weighted average shares, diluted57,972,00457,889,25555,651,48754,789,43560,447,34668,997,87959,994,539···
Weighted average shares, basic and diluted·····68,997,87959,994,53957,418,30046,587,63139,126,400
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton AGIO · research, not advice